Samuel J Danishefsky

USPTO Granted Patents = 94 (Patent Applications = 9)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 4.3

ph-index = 14

Forward Citations = 712(Granted Patents)

Forward Citations (Not Self Cited) = 485(Dec 10, 2025)

Inventors with similar research interests:

Location History:

New Haven, CT (US) (1992 - 1997)
Englewood, NY (US) (2003)
Englewood, NJ (US) (1997 - 2017)
New York, NY (US) (2019)

Company Filing History:

76 out of 512

Sloan-kettering Institute for Cancer Research

Nereus Pharmaceuticals, Inc.

patents

5. 1 out of 51,920

General Electric Company

patents

6. 1 out of 560

Memorial Sloan Kettering Cancer Center

Dana-farber-cancer Institute Inc.

patents

10. 1 out of 1,187

The Scripps Research Institute

patents

11. 3 out of 832,880

Other

patents

where one patent can have more than one assignee

Years Active: 1992-2019

Loading Chart...

Areas of Expertise:

Cyclic HIV-1 Env V3 Glycopeptide

Glycopeptide Constructs

Polyvalent Conjugate Vaccine

Migrastatins

Glycoconjugates

Erythropoietin

Epothilones

Salinosporamide A

Prostate Specific Antigens

HER-family Tyrosine Kinases

Macrocycles

Saframycin-Ecteinascidin

94 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10286057 - Cyclic HIV-1 Env V3 glycopeptide immunogens (2019-05-14),

2. 9598466 - Glycopeptide constructs and uses thereof (2017-03-21),

3. 9572875 - Polyvalent conjugate vaccine for cancer (2017-02-21),

4. 9546146 - Migrastatins and uses thereof (2017-01-17),

5. 9493580 - Multivalent glycopeptide constructs and uses thereof (2016-11-15),

6. 9464116 - Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof (2016-10-11),

7. 9303009 - Migrastatins and uses thereof (2016-04-05),

8. 9149516 - Polyvalent conjugate vaccine for cancer (2015-10-06),

9. 8957056 - Migrastatin analogs in the treatment of cancer (2015-02-17),

10. 8859615 - Compounds, compositions and methods for reducing toxicity and treating or preventing diseases (2014-10-14),

11. 8835693 - Migrastatin analogs and uses thereof (2014-09-16),

12. 8754192 - Compositions comprising homogeneously glycosylated erythropoietin (2014-06-17),

13. 8623378 - Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof (2014-01-07),

14. 8540964 - Polyvalent conjugate vaccine for cancer (2013-09-24),

15. 8513429 - Synthesis of epothilones, intermediates thereto and analogues thereof (2013-08-20),

Title: The Innovative Journey of Samuel J. Danishefsky

Introduction: Samuel J. Danishefsky, a distinguished inventor hailing from Englewood, NJ, has made significant contributions to the field of innovations and patents.

Latest Patents: Samuel J. Danishefsky holds several groundbreaking patents in the realm of organic chemistry and pharmaceuticals, showcasing his expertise and creativity in these areas.

Career Highlights: Throughout his illustrious career, Samuel J. Danishefsky has been a trailblazer in the development of novel synthetic methodologies and the total synthesis of complex natural products. His work has not only advanced the field of organic chemistry but has also paved the way for innovative drug discovery.

Collaborations: Samuel J. Danishefsky has collaborated with leading research institutions, pharmaceutical companies, and universities around the world, demonstrating his ability to work across disciplines and borders to achieve groundbreaking results.

Conclusion: In conclusion, Samuel J. Danishefsky's passion for innovation, coupled with his relentless pursuit of scientific excellence, has solidified his reputation as a visionary inventor in the world of organic chemistry and pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.